766P Levels of serum EGF concentration as biomarker of response of CIMAvax-EFG vaccine: Survival evaluation of advanced NSCLC patients treated in primary health care scenario

Autor: Otiz Carrodeguas, R.A., Lorenzo Monteagudo, G., Guerra, P.P., Sanchez, L., Cárdenas, L., Álvarez, I., Salomón, E.E., Díaz, M., Menéndez, Y., Lobaina, L., Columbié, J.C., Camacho, K., Corella, M., Fardales, N., Parra, J., Viada, C., Saavedra, D., Santos, O., Crombet Ramos, T.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S892-S892
Databáze: ScienceDirect